Simplex Trading
SLN

Simplex Trading’s Silence Therapeutics SLN Stock Holding History

Simplex Trading’s Portfolio SLN Stock Details SLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.4K Buy
5,500
+5,400
+5,400% +$38K ﹤0.01% 6111
2026
Q1 		$527 Hold
100
– – ﹤0.01% 8727
2025
Q4 		$608 Buy
+100
New +$640 ﹤0.01% 8130
2024
Q4 		– Sell
-200
Closed -$3K – 9538
2024
Q3 		$3K Buy
+200
New +$3.72K ﹤0.01% 7888

Other funds holding SLN

SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Simplex Trading's SLN Position: Q2 2026 in Review

Simplex Trading sold out of Silence Therapeutics (SLN) in Q2 2026, closing a stake of 612 shares — an estimated $4.31K sold.

Simplex Trading first reported a position in SLN in Q4 2024 and held it in 6 quarters. The position peaked at $24.3K in Q4 2025. 72 funds tracked by Wall St. Rank hold SLN as of Q2 2026.

  • Simplex Trading reported no remaining Silence Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 612 Silence Therapeutics shares in Q2 2026, an estimated $4.31K.
  • Simplex Trading first reported a position in Silence Therapeutics in Q4 2024 and held it in 6 quarters.
  • Simplex Trading's Silence Therapeutics position peaked at $24.3K in Q4 2025.
  • 72 funds tracked by Wall St. Rank held Silence Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.